An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer-MedSci.cn

An open-label, phase 2 study of patritumab deruxtecan in patients with previously treated advanced/metastatic colorectal cancer

Raghav, K; Yoshino, T; Taniguchi, H; Tejpar, S; Vogel, A; Wainberg, Z; Yamaguchi, K; Fakih, M; Pedersen, K; Bando, K; Kawakami, H; Beck, J; Kanai, M; Liu, Y; Mekan, S; Pudussery, G; Qiu, Y; Kopetz, S

ANNALS OF ONCOLOGY, 2021; 32 (): S111

科室
- - 订阅+
  - 更多科室
工具
服务